CoraLite® Plus 488-conjugated MYL3 Polyclonal antibody
MYL3 Polyclonal Antibody for IF/ICC, FC (Intra)
Host / Isotype
Rabbit / IgG
Reactivity
human, mouse, rat
Applications
IF/ICC, FC (Intra)
Conjugate
CoraLite® Plus 488 Fluorescent Dye
Cat no : CL488-10913
Synonyms
Validation Data Gallery
Tested Applications
Positive IF/ICC detected in | C2C12 cells |
Positive FC (Intra) detected in | C2C12 cells |
Recommended dilution
Application | Dilution |
---|---|
Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.80 ug per 10^6 cells in a 100 µl suspension |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
Product Information
CL488-10913 targets MYL3 in IF/ICC, FC (Intra) applications and shows reactivity with human, mouse, rat samples.
Tested Reactivity | human, mouse, rat |
Host / Isotype | Rabbit / IgG |
Class | Polyclonal |
Type | Antibody |
Immunogen | MYL3 fusion protein Ag1364 相同性解析による交差性が予測される生物種 |
Full Name | myosin, light chain 3, alkali; ventricular, skeletal, slow |
Calculated molecular weight | 22 kDa |
Observed molecular weight | 22-27 kDa |
GenBank accession number | BC009790 |
Gene symbol | MYL3 |
Gene ID (NCBI) | 4634 |
Conjugate | CoraLite® Plus 488 Fluorescent Dye |
Excitation/Emission maxima wavelengths | 493 nm / 522 nm |
Form | Liquid |
Purification Method | Antigen affinity purification |
Storage Buffer | PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
Storage Conditions | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
MYL3, also named as MLC1v, is an essential light chain of myosin that is associated with muscle contraction. It is expressed in ventricular and slow skeletal muscle. MYL3 may serve as a target for caspase-3 in dying cardiomyocytes. Mutations of MYL3 gene cause hypertrophic cardiomyopathy. MYL3 has been identified as potential serum biomarker for drug induced myotoxicity. Great increase in MYL3 serum concentration has been observed in rats with cardiac and skeletal muscle injury. (PMID:21685905)
Protocols
Product Specific Protocols | |
---|---|
IF protocol for CL Plus 488 MYL3 antibody CL488-10913 | Download protocol |
FC protocol for CL Plus 488 MYL3 antibody CL488-10913 | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |